Anne Burke

Medicine & Life Sciences

1. Contraceptive Agents 100%
2. Contraception 55%
3. Pregnancy 42%
4. Misoprostol 25%
5. Intrauterine Devices 24%
6. Family Planning Services 23%
7. Microbiota 20%
8. segesterone acetate and ethinyl estradiol vaginal system 18%
9. Long-Acting Reversible Contraception 17%
10. Hormonal Contraception 17%
11. Menopause 16%
12. First Pregnancy Trimester 14%
13. Progestins 13%
14. Confidence Intervals 13%
15. Postpartum Period 11%
16. Mifepristone 11%
17. Oral Contraceptives 11%
18. Counseling 11%
19. Randomized Controlled Trials 11%
20. Contraceptives, Oral, Combined 10%
21. Zika Virus 10%
22. Lactobacillus 10%
23. Chlamydia Infections 10%
24. Sexual Behavior 9%
25. Bariatric Surgery 9%
26. Young Adult 9%
27. Aftercare 9%
28. Postcoital Contraceptives 9%
29. Second Pregnancy Trimester 9%
30. Papillomavirus Infections 9%
31. Safety 9%
32. Chlamydia trachomatis 9%
33. Obesity 8%
34. drospirenone 8%
35. Hemorrhage 8%
36. Risk Assessment 8%
37. Prenatal Care 8%
38. Odds Ratio 8%
39. C 31G 8%
40. Pain 7%
41. Pandemics 7%
42. ST 1435 7%
43. Atrophy 7%
44. spleen fibrinolytic proteinase (human) 7%
45. Bacterial Vaginosis 7%
46. Female Contraceptive Devices 7%
47. nomegestrol acetate 7%
48. Estradiol 6%